Infusion of 3D cellular structures might repair damaged intestine

Infusion of 3D cellular structures might repair damaged intestine
Stem cells and functional differentiated cells in organoids support a faster repair of ulceration. Credit: Center for Stem Cell and Regenerative Medicine, TMDU

Ulcerative colitis is an inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in the digestive tract. Ulcerative colitis affects the innermost lining of the colon and rectum. It can be a debilitating condition and can sometimes lead to life-threatening complications. Most importantly, it does not have a cure at the moment.

In a recently published article, researchers from Tokyo Medical and Dental University (TMDU) have presented a detailed protocol for transplanting 3D cellular structures that can regenerate the that gets damaged in colitis. To develop this approach, they used a mouse model of colitis, obtained by the administration of dextran sulfate sodium, which destroys the in a way similar to colitis.

The 3D that the team transplanted are called organoids and represent one of the biggest revolutions in the field of biomedicine in the last decade. Organoids are a miniaturized and simplified version of an organ produced in the laboratory, made of agglomerates of cells; they are three-dimensional and show realistic micro-anatomy. Organoids are used for several applications, including as an in vitro tool to study diseases, for regenerative medicine, and to develop precision medicine approaches.

Infusion of 3D cellular structures might repair damaged intestine. Credit: Associate Professor Shiro Yui, TMDU

In the present study, the investigators used intestinal organoids to replace damaged intestinal tissue, a application. "We infused around 1000 organoids via a flexible catheter into the colon where most epithelial damage occurred. The cultured epithelial cells of the organoids attached to the injured surfaces and integrated into the host epithelium, the cell layer lining the inside of the colon," explains Satoshi Watanabe, lead author of the paper. "This resulted in an intact epithelium where part of the recipients' epithelial lining has been replaced by donor cells."

The total time taken for the rectal infusion of the organoids was 10 minutes, and, importantly, the researchers found that the method was reproducible across different culture conditions of the organoids. These features make it very attractive for a as it is a quick, reproducible, and minimally invasive method. Moreover, organoids can potentially be derived from the cells of the recipient patient, minimizing the risk of rejection after transplantation.

"This is a versatile protocol, which has been previously used to investigate cellular function, and formed the basis for the first-in-human clinical trial using colonic organoid transplantation therapy for hard-to-treat cases of ," explains Shiro Yui, senior author on the study. Thus, the protocol developed in this study has already been translated into clinical practice, and both the scientific and clinical communities are excited about the future clinical applications.

More information: Satoshi Watanabe et al, Transplantation of intestinal organoids into a mouse model of colitis, Nature Protocols (2022). DOI: 10.1038/s41596-021-00658-3

Provided by Tokyo Medical and Dental University
Citation: Infusion of 3D cellular structures might repair damaged intestine (2022, February 10) retrieved 4 December 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New research may pave the way to better treatments for Crohn's disease


Feedback to editors